Solubility and Permeability Measurement and Applications in Drug Discovery

被引:7
作者
Burton, Philip S. [1 ]
Goodwin, Jay T. [1 ]
机构
[1] ADMETRx Inc, Kalamazoo, MI 49008 USA
关键词
Solubility; permeability; ADME; in vitro; in silico; accuracy; absorption; pharmacokinetics; transporters; POLAR MOLECULAR-SURFACE; CACO-2 CELL MONOLAYERS; P-GLYCOPROTEIN; AQUEOUS SOLUBILITY; IN-VIVO; MEMBRANE-PERMEABILITY; ORAL ABSORPTION; COMPUTATIONAL PREDICTION; PHARMACOKINETIC MODELS; ORGANIC-COMPOUNDS;
D O I
10.2174/138620710790596763
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Solubility and cellular permeability are two of the most important biopharmaceutical properties impacting the successful development of drug substances. Given the importance of these properties, most pharmaceutical companies have invested in medium to high throughput technologies for early evaluation of these characteristics in the drug discovery funnel in order to select, prioritize or eliminate compounds with unfavorable solubility and/or permeability. However, these technologies require physical samples of the substances to be tested. In order to facilitate the early stages of drug discovery, such as defining compound collection composition, designing combinatorial libraries, and in hit expansion or lead optimization, models for predicting aqueous solubility and permeability in the absence of physical sample are increasingly being employed. In this overview, we will discuss solubility and permeability experimental and computational methods separately and then interrelate them in physiologically relevant models for predicting in vivo performance.
引用
收藏
页码:101 / 111
页数:11
相关论文
共 132 条
[1]   PASSIVE DIFFUSION OF WEAK ORGANIC ELECTROLYTES ACROSS CACO-2 CELL MONOLAYERS - UNCOUPLING THE CONTRIBUTIONS OF HYDRODYNAMIC, TRANSCELLULAR, AND PARACELLULAR BARRIERS [J].
ADSON, A ;
BURTON, PS ;
RAUB, TJ ;
BARSUHN, CL ;
AUDUS, KL ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) :1197-1204
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: The influence of culturing conditions and drug exposure on P-gp expression levels [J].
Anderle, P ;
Niederer, E ;
Rubas, W ;
Hilgendorf, C ;
Spahn-Langguth, H ;
Wunderli-Allenspach, H ;
Merkle, HP ;
Langguth, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) :757-762
[4]   PAMPA - Critical factors for better predictions of absorption [J].
Avdeef, Alex ;
Bendels, Stefanie ;
Di, Li ;
Faller, Bernard ;
Kansy, Manfred ;
Sugano, Kiyohiko ;
Yamauchi, Yukinori .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (11) :2893-2909
[5]   Solubility of sparingly-soluble ionizable drugs [J].
Avdeef, Alex .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :568-590
[6]   In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds:: Trends, problems and solutions [J].
Balakin, KV ;
Savchuk, NP ;
Tetko, IV .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (02) :223-241
[7]  
BALAKIN KV, 2003, CURR DRUG DISCOV AUG, P30
[8]   Current industrial practices of assessing permeability and P-glycoprotein interaction [J].
Balimane, PV ;
Han, YH ;
Chong, SH .
AAPS JOURNAL, 2006, 8 (01) :E1-E13
[9]  
Bassolino D, 1996, Drug Des Discov, V13, P135
[10]   Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? [J].
Behrens, I ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (05) :433-442